Jazz Pharma loses patent case over narcolepsy drug

28-02-2023

Liz Hockley

Jazz Pharma loses patent case over narcolepsy drug

T. Schneider / Shutterstock.com

Court finds no method-of-use in patent claims | Judgment is a win for rival firm Avadel.


Jazz Pharmaceuticals, Xyrem, Avadel, Lumryz, narcolepsy, GHB, Orange Book

LSIPR